Dentium (145720) - Total Assets
Based on the latest financial reports, Dentium (145720) holds total assets worth ₩932.79 Billion KRW (≈ $632.14 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 145720 net assets for net asset value and shareholders' equity analysis.
Dentium - Total Assets Trend (2015–2024)
This chart illustrates how Dentium's total assets have evolved over time, based on quarterly financial data.
Dentium - Asset Composition Analysis
Current Asset Composition (December 2024)
Dentium's total assets of ₩932.79 Billion consist of 53.3% current assets and 46.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 11.1% |
| Accounts Receivable | ₩164.93 Billion | 18.4% |
| Inventory | ₩148.22 Billion | 16.6% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩6.17 Billion | 0.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how Dentium's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 145720 stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dentium's current assets represent 53.3% of total assets in 2024, an increase from 47.9% in 2015.
- Cash Position: Cash and equivalents constituted 11.1% of total assets in 2024, up from 3.5% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 18.4% of total assets.
Dentium Competitors by Total Assets
Key competitors of Dentium based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Dentium - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.62 | 1.02 |
| Quick Ratio | 0.79 | 1.12 | 0.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩138.33 Billion | ₩183.23 Billion | ₩4.84 Billion |
Dentium - Advanced Valuation Insights
This section examines the relationship between Dentium's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.76 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 15.6% |
| Total Assets | ₩894.43 Billion |
| Market Capitalization | $311.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dentium's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Dentium's assets grew by 15.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dentium (2015–2024)
The table below shows the annual total assets of Dentium from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩894.43 Billion ≈ $606.14 Million |
+15.59% |
| 2023-12-31 | ₩773.77 Billion ≈ $524.37 Million |
+14.70% |
| 2022-12-31 | ₩674.58 Billion ≈ $457.16 Million |
+18.31% |
| 2021-12-31 | ₩570.20 Billion ≈ $386.42 Million |
+11.75% |
| 2020-12-31 | ₩510.24 Billion ≈ $345.78 Million |
-6.74% |
| 2019-12-31 | ₩547.11 Billion ≈ $370.77 Million |
+25.25% |
| 2018-12-31 | ₩436.83 Billion ≈ $296.03 Million |
+40.52% |
| 2017-12-31 | ₩310.87 Billion ≈ $210.67 Million |
+65.92% |
| 2016-12-31 | ₩187.36 Billion ≈ $126.97 Million |
+24.37% |
| 2015-12-31 | ₩150.64 Billion ≈ $102.09 Million |
-- |
About Dentium
Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly … Read more